Announcements Trials
Browse Landscape

Status

Completed 51Unknown 22Recruiting 15Terminated 9Withdrawn 7Active not recruiting 7Not yet recruiting 4Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 10Neoplasm Metastasis 1Adenocarcinoma 1

Interventions

zolbetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Adenocarcinoma × Tumor-Agnostic × Clear all
NCT06048081 2025-09-10

Early Access Program for Zolbetuximab

Astellas Pharma Inc

Available
Tumor-Agnostic

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡